Simplex Trading’s Corcept Therapeutics CORT Stock Holding History

Simplex Trading’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.49M	Sell	17,166 -52,349	-75%	-$3.16M	﹤0.01%	2333
2026 Q1	$2.8M	Sell	69,515 -39,822	-36%	-$1.49M	﹤0.01%	1542
2025 Q4	$3.8M	Buy	+109,337	New	+$8.59M	﹤0.01%	1487
2023 Q2	–	Sell	-138	Closed	-$3.18K	–	9096
2023 Q1	$2K	Buy	+138	New	+$3.02K	﹤0.01%	8429
2022 Q3	–	Sell	-165	Closed	-$4.42K	–	10017
2022 Q2	$3K	Buy	+165	New	+$3.6K	﹤0.01%	9118
2019 Q2	–	Sell	-13,320	Closed	-$148K	–	7186
2019 Q1	$156K	Buy	+13,320	New	+$166K	﹤0.01%	3870
2018 Q4	–	Sell	-1,229	Closed	-$16.2K	–	7094
2018 Q3	$17K	Buy	+1,229	New	+$17.2K	﹤0.01%	6075
2016 Q3	–	Sell	-286	Closed	-$1.66K	–	5862
2016 Q2	$1K	Sell	286 -499	-64%	-$2.6K	﹤0.01%	5238
2016 Q1	$3K	Buy	+785	New	+$3.06K	﹤0.01%	4429
2015 Q1	–	Sell	-37	Closed	-$134	–	5015
2014 Q4	$0	Buy	+37	New	+$113	﹤0.01%	4637

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Simplex Trading's CORT Position: Q2 2026 in Review

Simplex Trading reduced its Corcept Therapeutics (CORT) stake by 75% in Q2 2026, selling an estimated $3.16M and leaving 17,166 shares worth $1.49M. The position accounts for ﹤0.01% of the portfolio, ranked #2333.

Simplex Trading first reported a position in CORT in Q4 2014 and has held it in 10 quarters since. The position peaked at $3.8M in Q4 2025. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

Simplex Trading held 17,166 shares of Corcept Therapeutics worth $1.49M as of Q2 2026.
Simplex Trading sold 52,349 Corcept Therapeutics shares in Q2 2026, an estimated $3.16M.
Corcept Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #2333 holding.
Simplex Trading first reported a position in Corcept Therapeutics in Q4 2014 and has held it in 10 quarters since.
Simplex Trading's Corcept Therapeutics position peaked at $3.8M in Q4 2025.
422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.